These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 20123156

  • 1. Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity.
    Oda Y, Joho S, Harada D, Hirai T, Asanoi H, Inoue H.
    Auton Neurosci; 2010 Jun 24; 155(1-2):104-8. PubMed ID: 20123156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.
    Notarius CF, Butler GC, Ando S, Pollard MJ, Senn BL, Floras JS.
    Clin Sci (Lond); 1999 Jun 24; 96(6):557-65. PubMed ID: 10334961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure.
    Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, Gottlieb S, Ezra D, Lewis BS, Leor J.
    Eur Heart J; 2008 Apr 24; 29(8):1029-36. PubMed ID: 18339607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects.
    Notarius CF, Ando S, Rongen GA, Floras JS.
    Eur Heart J; 1999 Jun 24; 20(12):880-7. PubMed ID: 10329093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incremental value of renal function in risk prediction with the Seattle Heart Failure Model.
    Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J.
    Am Heart J; 2009 Feb 24; 157(2):299-305. PubMed ID: 19185637
    [Abstract] [Full Text] [Related]

  • 15. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 16. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, Lv AK, Zhang JS, Shen WF.
    Int J Cardiol; 2009 Jul 24; 136(1):72-9. PubMed ID: 18653250
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of oral beta blockade on cardiovascular and sympathetic regulation.
    Beloka SP, Gouveia S, Gujic M, Naeije R, Rocha AP, van de Borne P.
    J Cardiovasc Pharmacol Ther; 2009 Dec 24; 14(4):323-31. PubMed ID: 19903982
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.